RPG Life Sciences Ltd.

NSE: RPGLIFE | BSE: 532983 | ISIN: INE105J01010 | Industry: Pharmaceuticals
| Mid-range Performer
1921.2000 43.60 (2.32%)
NSE Apr 02, 2026 15:31 PM
Volume: 4,086
 

1921.20
2.32%
IDBI Capital
We recently met the management of RPG Life sciences (RPG). RPG is primarily engaged in manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs or bulk actives). RPG specializes in therapeutic areas like nephrology, oncology, urology, gastroenterology, pain management and nutritionals. RPG enjoys a strong brand recognition in anti-diarrheal, antacid, iron-vitamin, and nephrology segments. Domestic formulation 19% revenue growth YoY RPG has its manufacturing facilities in 1) Maharashtra and 2) Gujarat. RPG continues to strive to be a dominant player in specialty by focusing on differentiated products....
Number of FII/FPI investors decreased from 67 to 60 in Dec 2025 qtr
More from RPG Life Sciences Ltd.
Recommended